Outpatient use of bispecifics and CAR T-cell therapies in multiple myeloma can expand access.
Yi Lin, MD, PhD
Advertisement
Articles by Yi Lin, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights
1
ACIP Meeting: COVID-19 Vaccines to be Administered Through Shared Clinical Decision-Making
2
IMS 2025: Advancing Immunotherapy with Costimulatory Bispecific Antibodies in Multiple Myeloma
3
IMS 2025: Daratumumab Plus Lenalidomide Improves Outcomes in Post-Transplant Maintenance for Myeloma
4
Linvoseltamab Plus Carfilzomib Yields Deep, Durable Responses in Patients With RRMM
5
